116 related articles for article (PubMed ID: 35489389)
21. Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction.
Meakin PJ; Coull BM; Tuharska Z; McCaffery C; Akoumianakis I; Antoniades C; Brown J; Griffin KJ; Platt F; Ozber CH; Yuldasheva NY; Makava N; Skromna A; Prescott A; McNeilly AD; Siddiqui M; Palmer CN; Khan F; Ashford ML
J Clin Invest; 2020 Aug; 130(8):4104-4117. PubMed ID: 32407295
[TBL] [Abstract][Full Text] [Related]
22. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
23. Glutathionylation mediates angiotensin II-induced eNOS uncoupling, amplifying NADPH oxidase-dependent endothelial dysfunction.
Galougahi KK; Liu CC; Gentile C; Kok C; Nunez A; Garcia A; Fry NA; Davies MJ; Hawkins CL; Rasmussen HH; Figtree GA
J Am Heart Assoc; 2014 Apr; 3(2):e000731. PubMed ID: 24755153
[TBL] [Abstract][Full Text] [Related]
24. The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction.
Yamamoto E; Hirata Y; Tokitsu T; Kusaka H; Sakamoto K; Yamamuro M; Kaikita K; Watanabe H; Hokimoto S; Sugiyama S; Maruyama T; Ogawa H
Int J Cardiol; 2015; 190():335-7. PubMed ID: 25935623
[No Abstract] [Full Text] [Related]
25. [Polymorphism of eNOS and iNOS Genes and Chronic Heart Failure in Patients With Ischemic Heart Disease].
Tepliakov AT; Shilov SN; Berezikova EN; Iakovleva NF; Maianskaia SD; Popova AA; Luksha EB; Voronina EN; Torim IuIu; Karpov RS
Kardiologiia; 2010; 50(4):23-30. PubMed ID: 20459417
[TBL] [Abstract][Full Text] [Related]
26. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
27. Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size.
Li Q; Atochin D; Kashiwagi S; Earle J; Wang A; Mandeville E; Hayakawa K; d'Uscio LV; Lo EH; Katusic Z; Sessa W; Huang PL
Stroke; 2013 Nov; 44(11):3183-8. PubMed ID: 23988642
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from a murine type 2 diabetic model.
Taguchi K; Kobayashi T; Takenouchi Y; Matsumoto T; Kamata K
Pharmacol Res; 2011 Nov; 64(5):535-46. PubMed ID: 21571071
[TBL] [Abstract][Full Text] [Related]
29. [Association of polymorphism 4a/4b and 4b/4b in endothelial nitric oxide synthase gene and markers of endothelial dysfunction in patients with chronic heart failure].
Polunina EA; Voronina LP; Sevostyanova IV; Polunina OS; Tarasochkina DS
Kardiologiia; 2018 SApr; (S4):4-9. PubMed ID: 29782277
[TBL] [Abstract][Full Text] [Related]
30. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase.
Chalupsky K; Cai H
Proc Natl Acad Sci U S A; 2005 Jun; 102(25):9056-61. PubMed ID: 15941833
[TBL] [Abstract][Full Text] [Related]
31. High-intensity interval training attenuates endothelial dysfunction in a Dahl salt-sensitive rat model of heart failure with preserved ejection fraction.
Adams V; Alves M; Fischer T; Rolim N; Werner S; Schütt N; Bowen TS; Linke A; Schuler G; Wisloff U
J Appl Physiol (1985); 2015 Sep; 119(6):745-52. PubMed ID: 26229002
[TBL] [Abstract][Full Text] [Related]
32. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction.
de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
Oak JH; Cai H
Diabetes; 2007 Jan; 56(1):118-26. PubMed ID: 17192473
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC
Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159
[TBL] [Abstract][Full Text] [Related]
35. Restoration of Autophagic Flux Improves Endothelial Function in Diabetes Through Lowering Mitochondrial ROS-Mediated eNOS Monomerization.
Zhao L; Zhang CL; He L; Chen Q; Liu L; Kang L; Liu J; Luo JY; Gou L; Qu D; Song W; Lau CW; Ko H; Mok VCT; Tian XY; Wang L; Huang Y
Diabetes; 2022 May; 71(5):1099-1114. PubMed ID: 35179568
[TBL] [Abstract][Full Text] [Related]
36. Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function.
Otto M; Brabenec L; Müller M; Kintrup S; Hellenthal KEM; Holtmeier R; Steinbuch SC; Karsten OS; Pryvalov H; Rossaint J; Gross ER; Wagner NM
Life Sci; 2021 Nov; 284():119925. PubMed ID: 34480933
[TBL] [Abstract][Full Text] [Related]
37. The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by NO synthase inhibition by N-nitro-L-arginine methyl ester.
Billon A; Lehoux S; Lam Shang Leen L; Laurell H; Filipe C; Benouaich V; Brouchet L; Dessy C; Gourdy P; Gadeau AP; Tedgui A; Balligand JL; Arnal JF
Am J Pathol; 2008 Mar; 172(3):830-8. PubMed ID: 18276789
[TBL] [Abstract][Full Text] [Related]
38. Hypoglycaemia aggravates impaired endothelial-dependent vasodilation in diabetes by suppressing endothelial nitric oxide synthase activity and stimulating inducible nitric oxide synthase expression.
He A; Guo Y; Xu Z; Yan J; Xie L; Li Y; Lv D; Luo M
Microvasc Res; 2023 Mar; 146():104468. PubMed ID: 36513147
[TBL] [Abstract][Full Text] [Related]
39. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors.
Marrero MB; Venema VJ; Ju H; He H; Liang H; Caldwell RB; Venema RC
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):335-40. PubMed ID: 10510297
[TBL] [Abstract][Full Text] [Related]
40. Neuregulin-1 compensates for endothelial nitric oxide synthase deficiency.
Shakeri H; Boen JRA; De Moudt S; Hendrickx JO; Leloup AJA; Jacobs G; De Meyer GRY; De Keulenaer GW; Guns PDF; Segers VFM
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2416-H2428. PubMed ID: 33989083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
